Literature DB >> 19726683

Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.

Anne P Beigneux1, Peter Gin, Brandon S J Davies, Michael M Weinstein, André Bensadoun, Loren G Fong, Stephen G Young.   

Abstract

GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, binds lipoprotein lipase (LPL) avidly and is required for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 contains two key structural motifs, an acidic domain and an Ly6 motif (a three-fingered domain specified by 10 cysteines). The acidic domain is required for LPL binding, but the importance of the Ly6 domain is less clear. To explore that issue, we transfected cells with a wild-type GPIHBP1 expression vector or mutant GPIHBP1 vectors in which specific cysteines in the Ly6 domain were changed to alanine. The mutant GPIHBP1 proteins reached the cell surface, as judged by antibody binding studies and by the ability of a phosphatidylinositol-specific phospholipase C to release these proteins from the cell surface. However, cells expressing the cysteine mutants could not bind LPL. The acidic domain of the cysteine mutants appeared to remain accessible, as judged by binding studies with an antibody against the acidic domain. We also developed a cell-free assay of LPL binding. We created a rat monoclonal antibody against the carboxyl terminus of mouse GPIHBP1 and used that antibody to coat agarose beads. We then tested the ability of soluble forms of GPIHBP1 that had been immobilized on monoclonal antibody-coated beads to bind LPL. In this assay, wild-type soluble GPIHBP1 bound LPL avidly, but the cysteine mutants did not. Thus, our studies suggest that a structurally intact Ly6 domain (in addition to the acidic domain) is essential for LPL binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726683      PMCID: PMC2781579          DOI: 10.1074/jbc.M109.046391

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

2.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

Authors:  Anne P Beigneux; Brandon S J Davies; Peter Gin; Michael M Weinstein; Emily Farber; Xin Qiao; Franklin Peale; Stuart Bunting; Rosemary L Walzem; Jinny S Wong; William S Blaner; Zhi-Ming Ding; Kristan Melford; Nuttaporn Wongsiriroj; Xiao Shu; Fred de Sauvage; Robert O Ryan; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

3.  SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda.

Authors:  Bertrand Favre; Laure Plantard; Lorène Aeschbach; Noureddine Brakch; Stephanie Christen-Zaech; Pierre A de Viragh; Ann Sergeant; Marcel Huber; Daniel Hohl
Journal:  J Invest Dermatol       Date:  2006-09-28       Impact factor: 8.551

4.  Structure-function relationships of the complement regulatory protein, CD59.

Authors:  J Petranka; J Zhao; J Norris; N B Tweedy; R E Ware; P J Sims; W F Rosse
Journal:  Blood Cells Mol Dis       Date:  1996       Impact factor: 3.039

5.  Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.

Authors:  M Ploug
Journal:  Biochemistry       Date:  1998-11-24       Impact factor: 3.162

6.  Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain.

Authors:  A Hata; D N Ridinger; S Sutherland; M Emi; Z Shuhua; R L Myers; K Ren; T Cheng; I Inoue; D E Wilson
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

7.  Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis.

Authors:  R A Sendak; A Bensadoun
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

8.  Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.

Authors:  Anne P Beigneux; Remco Franssen; André Bensadoun; Peter Gin; Kristan Melford; Jorge Peter; Rosemary L Walzem; Michael M Weinstein; Brandon S J Davies; Jan A Kuivenhoven; John J P Kastelein; Loren G Fong; Geesje M Dallinga-Thie; Stephen G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-19       Impact factor: 8.311

9.  Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.

Authors:  Y Ma; H E Henderson; M S Liu; H Zhang; I J Forsythe; I Clarke-Lewis; M R Hayden; J D Brunzell
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

10.  Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands.

Authors:  Meera Mallya; R Duncan Campbell; Begoña Aguado
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

View more
  49 in total

1.  Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.

Authors:  Constance V Voss; Brandon S J Davies; Shelly Tat; Peter Gin; Loren G Fong; Christopher Pelletier; Charlene D Mottler; André Bensadoun; Anne P Beigneux; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase.

Authors:  André Bensadoun; Charlene D Mottler; Chris Pelletier; Daniel Wu; Jane J Seo; Calvin S Leung; Oludotun Adeyo; Chris N Goulbourne; Peter Gin; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  Biochim Biophys Acta       Date:  2014-03-28

3.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

4.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

5.  Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.

Authors:  Xuchen Hu; Mark W Sleeman; Kazuya Miyashita; MacRae F Linton; Christopher M Allan; Cuiwen He; Mikael Larsson; Yiping Tu; Norma P Sandoval; Rachel S Jung; Alaleh Mapar; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-11-15       Impact factor: 5.922

6.  Intravascular triglyceride lipolysis becomes crystal clear.

Authors:  Jay D Horton
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-04       Impact factor: 11.205

7.  GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.

Authors:  Brandon S J Davies; Anne P Beigneux; Richard H Barnes; Yiping Tu; Peter Gin; Michael M Weinstein; Chika Nobumori; Rakel Nyrén; Ira Goldberg; Gunilla Olivecrona; André Bensadoun; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2010-07-07       Impact factor: 27.287

8.  An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

Authors:  Christopher M Allan; Mikael Larsson; Xuchen Hu; Cuiwen He; Rachel S Jung; Alaleh Mapar; Constance Voss; Kazuya Miyashita; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; André Bensadoun; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-08-05       Impact factor: 5.922

9.  Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.

Authors:  Wanee Plengpanich; Stephen G Young; Weerapan Khovidhunkit; André Bensadoun; Hirankorn Karnman; Michael Ploug; Henrik Gårdsvoll; Calvin S Leung; Oludotun Adeyo; Mikael Larsson; Suwanna Muanpetch; Supannika Charoen; Loren G Fong; Sathit Niramitmahapanya; Anne P Beigneux
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

Review 10.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.